Today: 7 February 2026
Subscribe
Browse Category

NASDAQ:RNA News 27 October 2025

RNA Stock Skyrockets: Avidity Biosciences Soars on $12B Novartis Buyout and Breakthrough Trials

RNA Stock Skyrockets: Avidity Biosciences Soars on $12B Novartis Buyout and Breakthrough Trials

Stock Performance & Recent Trends Prior to the buyout news, RNA stock had been on a steady uptrend in 2025. The share price more than doubled from the low-$20s a year ago to the high-$40s this month ts2.tech. In the past three months alone, RNA jumped ~40%, fueled by upbeat clinical updates and M&A speculation ts2.tech. The stock hit a 52-week peak of $56 in early October ts2.tech after its lead DMD therapy showed strong results and secured FDA Breakthrough designation. Shares pulled back slightly to around $49 by late October, but remained up 100%+ year-over-year ts2.tech. A major catalyst
27 October 2025
······

Stock Market Today

Jardine Matheson stock slid 2.4% Friday — here’s what matters before Monday’s open

Jardine Matheson stock slid 2.4% Friday — here’s what matters before Monday’s open

7 February 2026
Singapore, Feb 7, 2026, 15:29 SGT — Market closed. Jardine Matheson Holdings fell 2.4% on Friday to close at $75.71 in its U.S. dollar counter on the Singapore Exchange, after trading between $75.30 and $78.83. About 293,900 shares changed hands, compared with 410,700 a day earlier. (Yahoo Finance) The move landed as regional markets cooled on a tech-led selloff and broader de-risking. Singapore’s shares fell 0.8% on the day, while investors tracked turbulence tied to U.S. tech and fresh debate over how quickly new AI tools could reshape software and services. “With U.S. tech wobbling, sentiments tend to trickle over
CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

CapitaLand Investment share price jumps as CapitaLand REIT payouts roll in — what’s next for 9CI

7 February 2026
CapitaLand Investment shares rose 1.3% to S$3.12 on Friday, bucking a 0.8% drop in Singapore’s benchmark index. CapitaLand Integrated Commercial Trust reported a 16.4% jump in second-half distributable income, while CapitaLand Ascendas REIT posted a 1.4% full-year rise. CapitaLand China Trust saw full-year DPU fall to 4.82 cents amid weaker yuan and occupancy. CLI reports FY2025 results on Feb. 11.
Go toTop